Nomura Holdings Inc. Takes Position in Maximus, Inc. (NYSE:MMS)

Nomura Holdings Inc. bought a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 7,970 shares of the health services provider's stock, valued at approximately $595,000.

Other institutional investors have also recently modified their holdings of the company. Fort Washington Investment Advisors Inc. OH grew its position in shares of Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock valued at $22,132,000 after acquiring an additional 83,390 shares during the period. IFP Advisors Inc grew its position in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Maximus during the 4th quarter valued at about $1,113,000. Legato Capital Management LLC grew its position in shares of Maximus by 33.9% during the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after acquiring an additional 8,138 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Maximus by 2.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after acquiring an additional 16,772 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Trading Down 0.5%

Shares of Maximus stock opened at $74.80 on Wednesday. The firm has a market capitalization of $4.21 billion, a PE ratio of 16.09 and a beta of 0.61. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The firm's 50-day moving average price is $69.04 and its 200 day moving average price is $72.49. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Maximus's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $1.57 EPS. On average, sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is 23.86%.

Insiders Place Their Bets

In other Maximus news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.